Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
3,588,107
-
Share change
-
-779,786
-
Total reported value
-
$154,367,900
-
Price per share
-
$43.01
-
Number of holders
-
68
-
Value change
-
-$32,885,765
-
Number of buys
-
19
-
Number of sells
-
38
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2018
As of 30 Jun 2018,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,588,107 shares.
The largest 10 holders included
DEUTSCHE BANK AG\, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, BNP PARIBAS ARBITRAGE, SA, JGP Global Gestao de Recursos Ltda., Baird Financial Group, Inc., Wharton Business Group, LLC, and UBS Group AG.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.